Future Challenges of Targeted Therapy of Cancers, 3rd Edition
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 1193
Special Issue Editor
Interests: hepatocellular carcinoma; histology; molecular biology; individualized therapy; epithelial mesenchymal transition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is a continuation of our previous Special Issue, “Future Challenges of Targeted Therapy of Cancers: 2nd Edition” (https://www.mdpi.com/journal/cimb/special_issues/73S5X6A77H).
The aim of this Special Issue is to gather together papers providing updates on targeted therapies for cancers. As individualized therapy is predicted to be mainly based on gene profiles, a deeper understanding of the genetic background is essential, spanning from cell lines to circulating tumor cells and tissue biomarkers. Data concerning the heterogeneity of tumors and a deep understanding of their environment could also have therapeutic impacts. Any research or review papers with potential implications for improving oncologic therapy are welcome, and we encourage the presentation of clinical trial results. If a submitted paper focuses mainly on in silico analyses or the examination of public gene databases, it should also include external validation of its study cohorts.
Prof. Dr. Simona Gurzu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- tumor tissue
- individualized therapy
- gene profile
- epithelial–mesenchymal transition
- immunotherapy
- angiogenesis
- metastases
- oncology
- pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
